P

Prime Medicine Inc
NASDAQ:PRME

Watchlist Manager
Prime Medicine Inc
NASDAQ:PRME
Watchlist
Price: 4.99 USD 2.04% Market Closed
Market Cap: 872.6m USD

Intrinsic Value

The intrinsic value of one PRME stock under the Base Case scenario is 1.2 USD. Compared to the current market price of 4.99 USD, Prime Medicine Inc is Overvalued by 76%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PRME Intrinsic Value
1.2 USD
Overvaluation 76%
Intrinsic Value
Price
P
Worst Case
Base Case
Best Case

Valuation History
Prime Medicine Inc

What is Valuation History?
Compare PRME to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PRME?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Prime Medicine Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Prime Medicine Inc

Current Assets 121.3m
Cash & Short-Term Investments 101.8m
Receivables 120k
Other Current Assets 19.4m
Non-Current Assets 157.7m
PP&E 144m
Other Non-Current Assets 13.7m
Efficiency

Free Cash Flow Analysis
Prime Medicine Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Prime Medicine Inc

Revenue
5m USD
Operating Expenses
-209.2m USD
Operating Income
-204.2m USD
Other Expenses
4.9m USD
Net Income
-199.3m USD
Fundamental Scores

PRME Profitability Score
Profitability Due Diligence

Prime Medicine Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Low 3Y Average Gross Margin
Low Gross Margin
Negative 3Y Average Net Margin
19/100
Profitability
Score

Prime Medicine Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

PRME Solvency Score
Solvency Due Diligence

Prime Medicine Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
53/100
Solvency
Score

Prime Medicine Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PRME Price Targets Summary
Prime Medicine Inc

Wall Street analysts forecast PRME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRME is 7.43 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.

Lowest
Price Target
4.04 USD
19% Downside
Average
Price Target
7.43 USD
49% Upside
Highest
Price Target
10.5 USD
110% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Prime Medicine Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for PRME is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

PRME Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one PRME stock?

The intrinsic value of one PRME stock under the Base Case scenario is 1.2 USD.

Is PRME stock undervalued or overvalued?

Compared to the current market price of 4.99 USD, Prime Medicine Inc is Overvalued by 76%.

Back to Top